Analyst Mayank Mamtani works at B. RILEY and is covering the the Healthcare sector with 365 price targets and ratings documented since 2018 spanning on 31 stocks. Previously, Mayank Mamtani worked at B. RILEY.
Mayank Mamtani's average stock forecast success ratio is 28.54% with an average time for price targets to be met of 125.32 days.
Most recent stock forecast was given on ICPT, Intercept Pharmaceuticals, Inc at 30-May-2023.
Analyst best performing recommendations are on VXRT.
The best stock recommendation documented was for NVAX (NOVAVAX, INC) at 5/18/2020. The price target of $53 was fulfilled within 2 days with a profit of $3.96 (6.95%) receiving and performance score of 34.76.
Average potential price target upside
Currently, out of the existing stock ratings of Mayank Mamtani - 2 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
2.5
$1.97 (371.70%)
3 months 24 days ago
0/1 (0%)
$1.86 (290.63%)
Buy
5
$4.47 (843.40%)
1 years 3 months 24 days ago
0/3 (0%)
$17.13 (296.23%)
Hold
16
2 years 9 months 8 days ago
0/4 (0%)
$28.54 (231.28%)
